Vascular remodeling and endothelial dysfunction in patients with occupational chronic obstructive pulmonary disease caused by exposure to industrial aerosol nanoparticles
- Authors: Shpagina L.A.1, Zenkova M.A.2, Saprykin A.I.3, Logashenko E.B.2, Shpagin I.S.1, Kotova O.S.1, Tsygankova A.R.3, Kondyurina E.G.1, Zelenskaya V.V.1, Kuznetsova G.V.1, Anikina E.V.1, Kamneva N.V.1, Sergeev V.A.1, Surovenko T.N.4
-
Affiliations:
- Novosibirsk State Medical University
- Institute of Chemical Biology and Fundamental Medicine of the Siberian Branch of the Russian Academy of Sciences
- Nikolaev Institute of Inorganic Chemistry of the Siberian Branch of the Russian Academy of Sciences
- Pacific State Medical University
- Issue: Vol 31, No 2 (2025)
- Pages: 127-138
- Section: Original Research Articles
- URL: https://journals.rcsi.science/0869-2106/article/view/313385
- DOI: https://doi.org/10.17816/medjrf643283
- ID: 313385
Cite item
Abstract
BACKGROUND: The characteristics of vascular pathology in different phenotypes of occupational chronic obstructive pulmonary disease (COPD), as well as the causal role of various industrial aerosol components, especially nanoparticles, are poorly understood.
AIM: To determine the characteristics of arterial remodeling and endothelial function in patients with occupational COPD caused by exposure to aerosol nanoparticles.
METHODS: An observational, cohort cross-sectional study was performed in patients with occupational COPD caused by exposure to aerosols containing metal (n = 48) or silicon (n = 55) nanoparticles, compared with COPD caused by tobacco smoking (n = 50). Scanning electron microscopy and inductively coupled plasma atomic emission spectroscopy were used to measure the size and chemical composition of particles, respectively. The procedures used in the study included color-flow duplex scanning of the brachiocephalic arteries, brachial arteries, and aorta; flow-mediated dilation test of the brachial arteries; and enzyme-linked immunosorbent assay of molecular markers. Linear regression was used to determine relationships.
RESULTS: The group of occupational COPD caused by aerosols with silicon nanoparticles had the highest values of carotid intima-media thickness: 1.2 [0.9; 1.5] mm; in the group of occupational COPD caused by aerosols with metal nanoparticles and the control group, these values were 0.9 [0.7; 1.0] mm and 0.8 [0.7; 0.9] mm, respectively (p = 0.009). Moreover, the group of occupational COPD caused by aerosols with silicon nanoparticles had the highest incidence of atherosclerosis compared to the group of occupational COPD caused by aerosols with metal nanoparticles and the control group (41.8% vs. 22.9% and 18.0%, respectively; р = 0.003). The aortic pulse wave velocity in the three groups was 12.6 [11.2; 14.1], 9.3 [8.9; 10.7], and 7.2 [6.9; 8.4] m/s, respectively (р = 0.001). The minimum flow-mediated dilation of the brachial arteries was 2.5 [2.1; 3.4], 3.8 [3.3; 4.6], and 4.7 [4.5; 5.3]%, respectively (р = 0.001). Occupational COPD caused by aerosols with silicon nanoparticles was associated with the highest serum levels of vascular cell adhesion molecule 1, von Willebrand factor, transforming growth factor β1, procollagen III N-terminal propeptide, and fibroblast growth factor 2. Regression relationships were found between the intima-media thickness and the concentration of metal (adjusted R-squared [R2]: 0.36) and silicon (adjusted R2: 0.47) nanoparticles, as well as the length of employment (adjusted R2: 0.27). Moreover, regression relationships were found between the flow-mediated dilation of the brachial arteries and the concentration of metal (adjusted R2: 0.51) and silicon (adjusted R2: 0.71) nanoparticles, the length of employment (adjusted R2: 0.68), and the total concentration of silicon-containing dust (adjusted R2: 0.55).
CONCLUSION: Occupational COPD caused by exposure to aerosol nanoparticles (especially silicon-containing ones) is associated with significant vascular remodeling and endothelial dysfunction, which must be considered during follow-up care.
Full Text
##article.viewOnOriginalSite##About the authors
Lyubov A. Shpagina
Novosibirsk State Medical University
Author for correspondence.
Email: lashpagina@gmail.com
ORCID iD: 0000-0003-0871-7551
SPIN-code: 5773-6649
MD, Dr. Sci. (Medicine), Professor
Russian Federation, NovosibirskMarina A. Zenkova
Institute of Chemical Biology and Fundamental Medicine of the Siberian Branch of the Russian Academy of Sciences
Email: marzen@niboch.nsc.ru
ORCID iD: 0000-0003-4044-1049
SPIN-code: 2284-2692
Dr. Sci. (Biology), Professor, Corresponding Member of the Russian Academy of Sciences
Russian Federation, NovosibirskAnatoly I. Saprykin
Nikolaev Institute of Inorganic Chemistry of the Siberian Branch of the Russian Academy of Sciences
Email: saprykin@niic.nsc.ru
ORCID iD: 0000-0002-8999-8457
SPIN-code: 4688-9801
Dr. Sci. (Engineering)
Russian Federation, NovosibirskEvgenia B. Logashenko
Institute of Chemical Biology and Fundamental Medicine of the Siberian Branch of the Russian Academy of Sciences
Email: evg.log@gmail.com
ORCID iD: 0000-0001-8977-5395
SPIN-code: 7408-9400
Cand. Sci. (Biology)
Russian Federation, NovosibirskIlya S. Shpagin
Novosibirsk State Medical University
Email: doctor_ilya@mail.ru
ORCID iD: 0000-0002-3109-9811
SPIN-code: 2892-6184
MD, Dr. Sci. (Medicine), Associate Professor
Russian Federation, NovosibirskOlga S. Kotova
Novosibirsk State Medical University
Email: ok526@yandex.ru
ORCID iD: 0000-0003-0724-1539
SPIN-code: 2488-0659
MD, Dr. Sci. (Medicine), Associate Professor
Russian Federation, NovosibirskAlfia R. Tsygankova
Nikolaev Institute of Inorganic Chemistry of the Siberian Branch of the Russian Academy of Sciences
Email: mkb-2@yandex.ru
ORCID iD: 0000-0001-7126-276X
SPIN-code: 6619-9694
Cand. Sci. (Chemistry)
Russian Federation, NovosibirskElena G. Kondyurina
Novosibirsk State Medical University
Email: econdur@yandex.ru
ORCID iD: 0000-0003-3250-3107
SPIN-code: 8665-9138
MD, Dr. Sci. (Medicine), Professor
Russian Federation, NovosibirskVera V. Zelenskaya
Novosibirsk State Medical University
Email: v.zelenskaya@mail.ru
ORCID iD: 0000-0003-0344-9412
SPIN-code: 9151-5099
MD, Dr. Sci. (Medicine), Associate Professor
Russian Federation, NovosibirskGalina V. Kuznetsova
Novosibirsk State Medical University
Email: doktor67@list.ru
ORCID iD: 0000-0001-7428-9159
MD, Cand. Sci. (Medicine)
Russian Federation, NovosibirskEkaterina V. Anikina
Novosibirsk State Medical University
Email: mkb-2@yandex.ru
ORCID iD: 0000-0002-6047-1707
SPIN-code: 3847-0025
Russian Federation, Novosibirsk
Natalya V. Kamneva
Novosibirsk State Medical University
Email: natali.spor@yandex.ru
ORCID iD: 0000-0003-3251-0315
SPIN-code: 8868-3043
MD, Cand. Sci. (Medicine)
Russian Federation, NovosibirskValery A. Sergeev
Novosibirsk State Medical University
Email: valerasergeev030197@yandex.ru
ORCID iD: 0009-0007-6984-4294
Russian Federation, Novosibirsk
Tatyana N. Surovenko
Pacific State Medical University
Email: mkb-2@yandex.ru
ORCID iD: 0000-0001-7676-3213
SPIN-code: 6169-4476
MD, Dr. Sci. (Medicine)
Russian Federation, VladivostokReferences
- Bystritskaya EV, Bilichenko TN. The morbidity, disability, and mortality associated with respiratory diseases in the Russian Federation (2015–2019). Pulmonologiya. 2021;31(5):551–561. doi: 10.18093/0869-0189-2021-31-5-551-561 EDN: KXDQEV
- Drapkina OM, Kontsevaya AV, Mukaneeva DK, et al. Forecast of the socioeconomic burden of COPD in the Russian Federation in 2022. Pulmonologiya. 2022;32(4):507–516. doi: 10.18093/0869-0189-2022-32-4-507-516 EDN: MZWUQY
- Egorenko SN, editor. Russian Statistical Yearbook. Moscow: Rosstat; 2023.
- Halpin DMG, Martinez FJ. Pharmacotherapy and mortality in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2022;206(10):1201–1207. doi: 10.1164/rccm.202205-1000PP EDN: ICYMFU
- Jiang R, Sun C, Yang Y, et al. Causal relationship between chronic obstructive pulmonary disease and heart failure: A Mendelian randomization study. Heart Lung. 2024;67:12–18. doi: 10.1016/j.hrtlng.2024.04.007 EDN: YRXATG
- Ingebrigtsen TS, Marott JL, Vestbo J, et al. Coronary heart disease and heart failure in asthma, COPD and asthma-COPD overlap. BMJ Open Respir Res. 2020;7(1):e000470. doi: 10.1136/bmjresp-2019-000470 EDN: TSOTJX
- Almagro P, Soler-Cataluña JJ, Huerta A, et al. Impact of comorbidities in COPD clinical control criteria. The CLAVE Study. BMC Pulm Med. 2024;24(1):6. doi: 10.1186/s12890-023-02758-0 EDN: TLJAXG
- Xue Z, Guo S, Liu X, et al. Impact of COPD or asthma on the risk of atrial fibrillation: a systematic review and meta-analysis. Front Cardiovasc Med. 2022;9:872446. doi: 10.3389/fcvm.2022.872446 EDN: SWAPQA
- Løkke A, Hilberg O, Lange P, et al. Exacerbations predict severe cardiovascular events in patients with COPD and stable cardiovascular disease — a nationwide, population-based cohort study. Int J Chron Obstruct Pulmon Dis. 2023;18:419–429. doi: 10.2147/COPD.S396790 EDN: KKVGHX
- Xu S, Gu Z, Zhu W, Feng S. Association of COPD with adverse outcomes in heart failure patients with preserved ejection fraction. ESC Heart Fail. 2024. doi: 10.1002/ehf2.14958 EDN: IKIZRO
- Shpagina LA, Kamneva NV, Shpagin IS, et al. Molecular markers in occupational chronic obstructive pulmonary disease comorbid with heart failure. Annals of the Russian Academy of Medical Sciences. 2020;75(5):541–551. doi: 10.15690/vramn1381 EDN: UARRQV
- Panev NI, Evseeva NA, Filimonov SN, et al. Risk factors for coronary heart disease in miners with anthracosilicosis. Russian Journal of Occupational Health and Industrial Ecology. 2021;61(3):161–167. doi: 10.31089/1026-9428-2021-61-3-161-167 EDN: WFOOKG
- Sorkina NS, Kuzmina LP, Artemova LV, Bezrukavnikova LM. Issues of the effects of lead on circulatory and respiratory diseases. Russian Journal of Occupational Health and Industrial Ecology. 2019;(12):983–988. doi: 10.31089/1026-9428-2019-59-12-983-988 EDN: FVGJXT
- Popova AYu, Onishchenko GG, Rakitskii VN. Hygiene in supporting scientific and technological development of the country and sanitary and epidemiological welfare of the population (to the 130th anniversary of the Federal Scientific Centre of Hygiene named after F.F. Erisman). Hygiene and Sanitation, Russian Journal. 2021;100(9):882–889. doi: 10.47470/0016-9900-2021-100-9-882-889 EDN: OXJKGH
- Shpagina LA, Zenkova MA, Saprykin AI, et al. The role of nanoparticles of industrial aerosols in the formation of occupational bronchopulmonary pathology. Russian Journal of Occupational Health and Industrial Ecology. 2024;64(2):111–120. doi: 10.31089/1026-9428-2024-64-2-111-120 EDN: DBXTZJ
- Chuchalin AG, Avdeev SN, Aisanov ZR, et al. Federal guidelines on diagnosis and treatment of chronic obstructive pulmonary disease. Pulmonologiya. 2022;32(3):356–392. doi: 10.18093/0869-0189-2022-32-3-356-392 EDN: ANYVUN
- Aboyans V, Ricco JB, Bartelink MEL, et al. 2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS): Document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteries endorsed by: the European Stroke Organization (ESO) The Task Force for the Diagnosis and Treatment of Peripheral Arterial Diseases of the European Society of Cardiology (ESC) and of the European Society for Vascular Surgery (ESVS). Eur Heart J. 2018;39(9):763–816. doi: 10.1093/eurheartj/ehx095 EDN: VFJGYP
- Vaes AW, De Boever P, Franssen FME, et al. Endothelial function in patients with COPD: an updated systematic review of studies using flow-mediated dilatation. Expert Rev Respir Med. 2023;17(1):53–69. doi: 10.1080/17476348.2023.2176845 EDN: XULOKC
- Georgiopoulos G, Mavraganis G, Delialis D, et al. Carotid ultrasonography improves residual risk stratification in guidelines-defined high cardiovascular risk patients. Eur J Prev Cardiol. 2022;29(13):1773–1784. doi: 10.1093/eurjpc/zwac095 EDN: ULONSP
- Malyutina NN, Yuy ND, Luzina SV, et al. Prognosis of forming phenotype of comorbidity of arterial hypertension and erosive-ulcerative lesions of gastroduodenal zone in railway transport workers. Perm Medical Journal. 2022;39(6):17–27. doi: 10.17816/pmj39617-27 EDN: ZMAHMW
- Mancusi C, Manzi MV, de Simone G, et al. Carotid atherosclerosis predicts blood pressure control in patients with hypertension: the Campania Salute Network Registry. J Am Heart Assoc. 2022;11(5):e022345. doi: 10.1161/JAHA.121.022345 EDN: MQPFMP
- Nevzorova VA, Zakharchuk NV, Shapkina EU, et al. COPD and preclinical cardiovascular disease. South Russian Journal of Therapeutic Practice. 2021;2(2):70–79. doi: 10.21886/2712-8156-2021-2-2-70-79 EDN: BIEKCD
- Watanabe K, Onoue A, Omori H, et al. Association between airflow limitation and carotid intima-media thickness in the Japanese population. Int J Chron Obstruct Pulmon Dis. 2021;16:715–726. doi: 10.2147/COPD.S291477 EDN: ROTOMG
- Zhang X, Zhang S, Huang Q, et al. Comparison of arterial stiffness and ultrasound indices in patients with and without chronic obstructive pulmonary disease. Rev Assoc Med Bras (1992). 2022;68(5):605–609. doi: 10.1590/1806-9282.2021203 EDN: JYMWCW
- Screm G, Mondini L, Salton F, et al. Vascular endothelial damage in COPD: where are we now, where will we go? Diagnostics (Basel). 2024;14(9):950. doi: 10.3390/diagnostics14090950 EDN: LABQLL
- Yu GH, Fang Y. Resveratrol attenuates atherosclerotic endothelial injury through the Pin1/Notch1 pathway. Toxicol Appl Pharmacol. 2022;446:116047. doi: 10.1016/j.taap.2022.116047 EDN: DOLRDO
Supplementary files
